PCM
TMCI icon

Prelude Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Prelude Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,400
Closed -$528K – 1521
2023
Q4 		$528K Buy
41,400
+5,400
+15% +$54.6K 0.04% 488
2023
Q3 		$472K Buy
36,000
+20,001
+125% +$366K 0.03% 486
2023
Q2 		$409K Buy
+15,999
New +$413K 0.03% 539

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Prelude Capital Management's TMCI Position: Q1 2024 in Review

Prelude Capital Management sold out of Treace Medical Concepts (TMCI) in Q1 2024, closing a stake of 41,400 shares — an estimated $528K sold.

Prelude Capital Management first reported a position in TMCI in Q2 2023 and held it in 3 quarters. The position peaked at $528K in Q4 2023. 132 funds tracked by Wall St. Rank hold TMCI as of Q1 2024.

  • Prelude Capital Management reported no remaining Treace Medical Concepts position as of Q1 2024 after selling out during the quarter.
  • Prelude Capital Management sold 41,400 Treace Medical Concepts shares in Q1 2024, an estimated $528K.
  • Prelude Capital Management first reported a position in Treace Medical Concepts in Q2 2023 and held it in 3 quarters.
  • Prelude Capital Management's Treace Medical Concepts position peaked at $528K in Q4 2023.
  • 132 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.